A First in Human Study of ORT247 in Healthy Volunteers

NCT06769620 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

DRUG: ORT247
DRUG: Placebo

Sponsor

Orthogonal Neuroscience Inc.